Piper Sandler lowered the firm’s price target on Xponential Fitness (XPOF) to $12 from $13 and keeps a Neutral rating on the shares following “solid” results. Piper acknowledged that efforts are going to take time to materialize and come with uncertainty around forward expectations that could inhibit more meaningful multiple expansion, the firm told investors in a research note. The firm added that it continues to remain on the sidelines until more significant improvements are made.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XPOF: